Entropy Technologies LP Has $5.24 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Entropy Technologies LP lowered its position in CVS Health Co. (NYSE:CVS) by 4.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 116,742 shares of the pharmacy operator’s stock after selling 5,098 shares during the period. Entropy Technologies LP’s holdings in CVS Health were worth $5,241,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health in the third quarter valued at about $25,000. Livelsberger Financial Advisory bought a new position in CVS Health during the third quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new position in CVS Health during the third quarter valued at about $31,000. Reston Wealth Management LLC bought a new position in CVS Health during the third quarter valued at about $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new position in CVS Health during the third quarter valued at about $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 0.5 %

CVS stock opened at $53.95 on Friday. The company has a market capitalization of $67.90 billion, a PE ratio of 13.69, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The company’s 50 day moving average price is $50.79 and its two-hundred day moving average price is $56.01. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm posted $2.21 earnings per share. As a group, analysts predict that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.93%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Analyst Ratings Changes

A number of brokerages have weighed in on CVS. Barclays cut their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. StockNews.com lowered shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Truist Financial cut their target price on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Evercore ISI increased their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Monday, January 27th. Finally, UBS Group raised their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.